Advance and challenge of DNA methylation as cancer biomarkers for risk stratification, screening and early detection.
- DOI
- 10.1016/j.jncc.2024.12.007
- Published
- 2025 Apr
- Container
- Journal of the National Cancer Center
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.jncc.2024.12.007,
title = {Advance and challenge of DNA methylation as cancer biomarkers for risk stratification, screening and early detection.},
author = {Li N and Song K and Chen H and Dai M},
year = {2025},
journal = {Journal of the National Cancer Center},
doi = {10.1016/j.jncc.2024.12.007},
url = {https://doi.org/10.1016/j.jncc.2024.12.007}
}RIS
TY - JOUR TI - Advance and challenge of DNA methylation as cancer biomarkers for risk stratification, screening and early detection. AU - Li N AU - Song K AU - Chen H AU - Dai M PY - 2025 JO - Journal of the National Cancer Center DO - 10.1016/j.jncc.2024.12.007 UR - https://doi.org/10.1016/j.jncc.2024.12.007 ER -
APA
N, L., K, S., H, C., & M, D. (2025). Advance and challenge of DNA methylation as cancer biomarkers for risk stratification, screening and early detection.. Journal of the National Cancer Center. https://doi.org/10.1016/j.jncc.2024.12.007
Source records
- pubmed · retrieved 2026-09-26T08:34:18.113Z